LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Book ; Thesis: Mukoviszidose - eine Erkrankung auf dem Weg zur personalisierten Medizin

    Koningsbruggen-Rietschel, Silke van

    = Cystic Fibrosis - personalised medicine comes to CF

    2018  

    Title variant Cystic Fibrosis - personalised medicine comes to CF
    Institution Klinik und Poliklinik für Kinder- und Jugendmedizin
    Author's details vorgelegt von Dr. med. Silke van Koningsbruggen-Rietschel ; aus der Klinik und Poliklinik für Kinder- und Jugendmedizin der Universität zu Köln
    Subject code 610
    Language German
    Size 73 Blätter, Illustrationen, Diagramme
    Publishing place Köln
    Publishing country Germany
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Habilitationsschrift, Universität zu Köln, 2019
    HBZ-ID HT020283343
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  2. Article ; Online: Inhaled antimicrobial prescribing for Pseudomonas aeruginosa infections in Europe.

    Sloan, Callum M / Sherrard, Laura J / Einarsson, Gisli G / Dupont, Lieven J / Koningsbruggen-Rietschel, Silke van / Simmonds, Nicholas J / Downey, Damian G

    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

    2024  

    Abstract: Background: Prescribers have an increasing range of inhaled antimicrobial formulations to choose from when prescribing both eradication and chronic suppression regimens in cystic fibrosis (CF). This study aimed to investigate the decision-making process ...

    Abstract Background: Prescribers have an increasing range of inhaled antimicrobial formulations to choose from when prescribing both eradication and chronic suppression regimens in cystic fibrosis (CF). This study aimed to investigate the decision-making process behind prescribing of inhaled antimicrobials for Pseudomonas aeruginosa infections.
    Methods: A questionnaire was developed using Microsoft Forms and then forwarded to 57 Principal Investigators (PIs), at each of the CF centres within the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN). Data collection occurred between November 2021 and February 2022.
    Results: The response rate was 90 % (n = 51/57 PIs), with at least 50 % of CF centers in each of the 17 countries represented in the ECFS-CTN. Physicians used a median of eight factors in their decision-making process with delivery formulations (92.2 %), adherence history (84.3 %), and antibiotic side-effect profile (76.5 %) often selected. Nebulised tobramycin or colistin were frequently selected as the inhaled antimicrobial in first-line eradication (n = 45, 88.2 %) and chronic suppression regimens (n = 42, 82.4 %). Combination regimens were more often chosen in eradication (first-line: n = 35, 68.6 %, second-line: n = 34, 66.7 %) and later chronic suppression regimens (third-line: n = 27, 52.9 %) than monotherapy. For pwCF also prescribed CFTR modulator therapies, most PIs did not alter inhaled antimicrobial regimens (n = 40, 78.4 %), with few pwCF (n = 18, 35.3 %) or PIs (n = 10, 19.6 %) deciding to stop inhaled antimicrobials.
    Conclusions: The inhaled antimicrobial prescribing decision-making process is multifactorial. Nebulised tobramycin or colistin are often used in initial eradication and chronic suppression regimens. To date, CFTR modulator therapy has had a limited impact on the prescribing of inhaled antimicrobial regimens.
    Language English
    Publishing date 2024-02-14
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2084724-5
    ISSN 1873-5010 ; 1569-1993
    ISSN (online) 1873-5010
    ISSN 1569-1993
    DOI 10.1016/j.jcf.2023.11.012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Book ; Thesis: Entwicklungsneurologische Charakterisierung der Spontanmotorik in den ersten vier Lebensmonaten bei Termingeborenen und Frühgeborenen

    Koningsbruggen-Rietschel, Silke van

    1998  

    Author's details vorgelegt von Silke van Koningsbruggen
    Language German
    Size 229 Bl. : graph. Darst.
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Heidelberg, Univ., Diss., 1999
    HBZ-ID HT011107149
    Database Catalogue ZB MED Medicine, Health

    Kategorien

To top